Total Liabilities for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported total liabilities is $33.94B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$33.94B
YoY change
+1.3%
5Y CAGR
-3.0%
Peak year (2017)
$45.15B
Latest annual
$33.94B
Total Liabilities history chart for Abbott Laboratories (ABT) from 1985 to 2025
Total Liabilities history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $33.94B | +1.3% | ||
| 2024 | $33.51B | -2.5% | ||
| 2023 | $34.39B | -8.4% | ||
| 2022 | $37.53B | -4.2% | ||
| 2021 | $39.17B | -0.9% | ||
| 2020 | $39.55B | +8.1% | ||
| 2019 | $36.59B | +0.4% | ||
| 2018 | $36.45B | -19.3% | ||
| 2017 | $45.15B | +41.3% | ||
| 2016 | $31.95B | +60.4% | ||
| 2015 | $19.92B | +1.5% | ||
| 2014 | $19.64B | +11.0% | ||
| 2013 | $17.69B | -56.2% | ||
| 2012 | $40.42B | +13.1% | ||
| 2011 | $35.75B | -3.3% | ||
| 2010 | $36.99B | +25.3% | ||
| 2009 | $29.52B | +18.4% | ||
| 2008 | $24.94B | +13.7% | ||
| 2007 | $21.94B | -0.9% | ||
| 2006 | $22.12B | +50.2% | ||
| 2005 | $14.73B | +2.0% | ||
| 2004 | $14.44B | +5.9% | ||
| 2003 | $13.64B | +0.4% | ||
| 2002 | $13.59B | -4.5% | ||
| 2001 | $14.24B | +112.1% | ||
| 2000 | $6.71B | -4.7% | ||
| 1999 | $7.04B | -6.1% | ||
| 1998 | $7.50B | +6.2% | ||
| 1997 | $7.06B | +12.0% | ||
| 1996 | $6.31B | +25.7% | ||
| 1995 | $5.02B | +12.1% | ||
| 1994 | $4.47B | +11.5% | ||
| 1993 | $4.01B | +11.7% | ||
| 1992 | $3.59B | +17.7% | ||
| 1991 | $3.05B | +11.8% | ||
| 1990 | $2.73B | +28.4% | ||
| 1989 | $2.13B | -10.0% | ||
| 1988 | $2.36B | +3.0% | ||
| 1987 | $2.29B | +9.8% | ||
| 1986 | $2.09B | +30.6% | ||
| 1985 | $1.60B | — |
Total Liabilities values are taken from Abbott Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Abbott Laboratories (ABT) total liabilities totalled $33.94B – edged up 1.3% year-over-year.
Across 2020–2025 (5 years), Abbott Laboratories total liabilities produced a CAGR of -3.0% – with a net decline across the window.
The highest annual total liabilities of $45.15B was reported in 2017. The lowest in the available history was $1.60B in 1985.
Abbott Laboratories (ABT) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
Abbott Laboratories Total Liabilities by Year
Abbott Laboratories Total Liabilities 2025: $33.94B
Abbott Laboratories total liabilities in 2025 was $33.94B, edged up 1.3% from 2024.
Abbott Laboratories Total Liabilities 2024: $33.51B
Abbott Laboratories total liabilities in 2024 was $33.51B, edged down 2.5% below 2023.
Abbott Laboratories Total Liabilities 2023: $34.39B
Abbott Laboratories total liabilities in 2023 was $34.39B, declined 8.4% below 2022.
Abbott Laboratories Total Liabilities 2022: $37.53B
Abbott Laboratories total liabilities in 2022 was $37.53B, edged down 4.2% below 2021.
Abbott Laboratories Total Liabilities 2021: $39.17B
Abbott Laboratories total liabilities in 2021 was $39.17B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Total Liabilities
Companies in the same sector as Abbott Laboratories, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's total liabilities?
- Latest reported total liabilities for Abbott Laboratories (ABT) is $33.94B (period ending December 31, 2025).
How has Abbott Laboratories total liabilities changed year-over-year?
- Abbott Laboratories (ABT) total liabilities changed +1.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories total liabilities?
- Abbott Laboratories (ABT) total liabilities compound annual growth rate is -3.0% over the most recent 5 years available.
When did Abbott Laboratories total liabilities hit its highest annual value?
- Abbott Laboratories total liabilities reached its highest annual value of $45.15B in 2017.
What was Abbott Laboratories total liabilities in 2024?
- Abbott Laboratories (ABT) total liabilities in 2024 was $33.51B.
What was Abbott Laboratories total liabilities in 2025?
- Abbott Laboratories (ABT) total liabilities in 2025 was $33.94B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.